Abstract
Clinical Innovation Network (CIN) is a new collaboration scheme with National Medical Research Centers (NCs) and industries, which was proposed by Ministry of Health, Labor and Welfare in 2015. In CIN, each NC will make patient registries to search disease related information. Purpose of CIN is to facilitate clinical development in Japan by effective utilization of medical information from patient registries. Pharmaceutical companies will make a consortium with NC, and will be able to use the information from patient registries through the consortium activities. Pharmaceutical companies highly expect the CIN activity because patient registry will be useful for promoting the patient recruitment to clinical trials as well as for generating the reference data for clinical study protocols.
